APA (7th ed.) Citation

AS, H., JW, C., E, C., MA, P., M, Z., S, M., & CA, Y. (2025). Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma. Biomedicines, 13(1), . https://doi.org/10.3390/biomedicines13010201

Chicago Style (17th ed.) Citation

AS, Himstead, Chen JW, Chu E, Perez-Rosendahl MA, Zheng M, Mathew S, and Yuen CA. "Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma." Biomedicines 13, no. 1 (2025). https://doi.org/10.3390/biomedicines13010201.

MLA (9th ed.) Citation

AS, Himstead, et al. "Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma." Biomedicines, vol. 13, no. 1, 2025, https://doi.org/10.3390/biomedicines13010201.